140 related articles for article (PubMed ID: 7006795)
41. Malignant lymphomas as tumours of the immune system.
Berard CW; Cossman J; Jaffe ES
Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
[TBL] [Abstract][Full Text] [Related]
42. Current views on the diagnosis of lymphomas by surface and cytoplasmic markers.
Lewis RE; Johnson WW; Cruse JM
Surv Immunol Res; 1982; 1(2):162-72. PubMed ID: 6314466
[No Abstract] [Full Text] [Related]
43. Objective regressions of T- and B-cell lymphomas in patients following treatment with anti-thymocyte globulin.
Fisher RI; Silver BA; Vanhaelen CP; Jaffe ES; Cossman J
Cancer Res; 1982 Jun; 42(6):2465-9. PubMed ID: 7042086
[TBL] [Abstract][Full Text] [Related]
44. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
45. Surface markers for characterisation of bovine blood lymphocyte populations and changes in these from birth to maturity.
Outteridge PM; Dufty JH
Res Vet Sci; 1981 Nov; 31(3):315-22. PubMed ID: 6210941
[TBL] [Abstract][Full Text] [Related]
46. Surface markers define human lymphoid malignancies with differing prognoses.
Kersey J; Coccia P; Bloomfield C; Nesbit M; McKenna R; Brunning R; Hallgren H; Gajl-Peczalska K
Haematol Blood Transfus; 1977; 20():17-24. PubMed ID: 305392
[No Abstract] [Full Text] [Related]
47. Adult non-Hodgkin's lymphoma. Correlation of cell surface marker phenotype with prognosis, the new working formulation, and the Rappaport and Lukes-Collins histomorphologic schemes.
Rudders RA; DeLellis RA; Ahl ET; Bernstein S; Begg CB
Cancer; 1983 Dec; 52(12):2289-99. PubMed ID: 6640501
[TBL] [Abstract][Full Text] [Related]
48. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
[TBL] [Abstract][Full Text] [Related]
49. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
Bloomfield CD; Gajl-Peczalska KJ
Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
[No Abstract] [Full Text] [Related]
50. Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--should peripheral T-cell lymphoma be considered separately?
Cheng AL; Chen YC; Wang CH; Su IJ; Hsieh HC; Chang JY; Hwang WS; Su WC; Liu TW; Tien HF
J Clin Oncol; 1989 Jun; 7(6):725-31. PubMed ID: 2654330
[TBL] [Abstract][Full Text] [Related]
51. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
Borowitz MJ; Croker BP; Metzgar RS
Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
[TBL] [Abstract][Full Text] [Related]
52. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
[TBL] [Abstract][Full Text] [Related]
53. [B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum].
Schwarze EW; Pileri S; Stein H; Palestro G; Tolksdorf G
Klin Padiatr; 1982; 194(4):226-32. PubMed ID: 6982372
[TBL] [Abstract][Full Text] [Related]
54. Lymphocyte subpopulations bearing different surface markers in non-Hodgkin lymphoma.
Hołowiecki J; Japa J; Szeruda-Rudzka E; Stella-Hołowiecka B; Krawczyk M; Jarczok K; Rosa B
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):845-9. PubMed ID: 749833
[TBL] [Abstract][Full Text] [Related]
55. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
Tubiana N; Derre M; Carcassonne Y
Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
[TBL] [Abstract][Full Text] [Related]
56. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
57. Identification of human lymphoma cells by antisera to malignancy-associated nucleolar antigens.
Ford RJ; Cramer M; Davis FM
Blood; 1984 Mar; 63(3):559-65. PubMed ID: 6365200
[TBL] [Abstract][Full Text] [Related]
58. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
59. Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin's lymphomas: a retrospective evaluation of 1,792 cases.
Demurtas A; Stacchini A; Aliberti S; Chiusa L; Chiarle R; Novero D
Cytometry B Clin Cytom; 2013 Mar; 84(2):82-95. PubMed ID: 23325563
[TBL] [Abstract][Full Text] [Related]
60. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
